| Pharmaceutical active ingredients: |
| Propafenone Hydrochloride |
| Available forms, composition and doses of Prolekofen: |
| Injectable; Injection; Propafenone Hydrochloride 0.35%Tablets; Oral; Propafenone Hydrochloride 150 mgTablets; Oral; Propafenone Hydrochloride 300 mg |
| Prolekofen medical category: |
| Human:Cardiac drugsClass IC antiarrythmics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BC03 - Propafenone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Lek |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nistaken | Propafenone Hydrochloride | Kendrick Laboratorios |
| Norfenon | Propafenone Hydrochloride | Abbott |
| Normorytmin | Propafenone Hydrochloride | Abbott; Knoll |
| PMS-Propafenone | Propafenone Hydrochloride | Pharmascience |
| Profex | Propafenone Hydrochloride | Taro Pharmaceutical Industries |
| Propafen | Propafenone Hydrochloride | BASF |
| Propafenon | Propafenone Hydrochloride | Aliud Pharma |
| Propafenon | Propafenone Hydrochloride | CT-Arzneimittel |
| Propafenon | Propafenone Hydrochloride | Genericon Pharma |
| Propafenon | Propafenone Hydrochloride | Hexal |